These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Biotherapy with interferon--1988. Figlin RA Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749 [TBL] [Abstract][Full Text] [Related]
15. Induction of anti-tumor activity following autologous stem cell transplantation: immunotherapeutic implications. Marin GH; Menna ME; Bergna MI; Malacalza J; Martin C; Mendez MC; Klein G; Montero-Labat L; Gil MA; Saba S; Gardenal L; Mansilla E; Orlando S; Canepa C; Piccinelli G Transplant Proc; 2001; 33(1-2):2004-7. PubMed ID: 11267604 [No Abstract] [Full Text] [Related]
16. Clinical and biological activity of the interferons in hematologic malignancies. Gutterman JU Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111 [No Abstract] [Full Text] [Related]
17. [Aspects of molecular remission in hematology and oncology]. Novik AA; Kamilova TA; Tsygan VN Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823 [No Abstract] [Full Text] [Related]
18. Interferons for the treatment of hematological malignancies. Urabe A Oncology; 1994; 51(2):137-41. PubMed ID: 7515169 [TBL] [Abstract][Full Text] [Related]
19. The current status of interferon alpha in haemic malignancy. Galvani DW; Cawley JC Blood Rev; 1990 Sep; 4(3):175-80. PubMed ID: 2245253 [TBL] [Abstract][Full Text] [Related]
20. Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2',5'oligoadenylate system and clinical response. de Mel WC; Hoffbrand AV; Giles FJ; Goldstone AH; Mehta AB; Ganeshaguru K Br J Haematol; 1990 Apr; 74(4):452-6. PubMed ID: 2346724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]